Esper Kallas

12PUBLICATIONS
121CO-AUTHORS
Predictive and prognostic markersAgricultural molecular engineering of nucleic acids and proteinsInnate immunityAutoimmunityVenereology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 19, 2023
Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors).

Lívia Pimenta Bonifácio, Eduardo Ramacciotti, Leandro Barile Agati

|Mar 29, 2023
Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection.

Michael J Ricciardi, Lauren N Rust, Nuria Pedreño-Lopez

|Feb 08, 2023
Expression of TIGIT, PD-1 and HLA-DR/CD38 markers on CD8-T cells of children and adolescents infected with HIV and uninfected controls.

Wânia Ferraz Pereira-Manfro, Giselle Pereira da Silva, Priscilla Ramos Costa

|Nov 29, 2021
Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases.

Adriana Coracini Tonacio, Tatiana do Nascimento Pedrosa, Eduardo Ferreira Borba

|Oct 06, 2021
Association between circulating exhausted CD4+ T cells with poor meningococcal C conjugate vaccine antibody response in HIV-infected children and adolescents.

Giselle P Silva, Wania F Pereira-Manfro, Priscilla R Costa

|Feb 10, 2021
Radiological patterns of incidental epididymitis in mild-to-moderate COVID-19 patients revealed by colour Doppler ultrasound.

Felipe Carneiro, Thiago A Teixeira, Felipe S Bernardes

Pageof 2

Frequent Collaborators

2 joint publications

Paulo H N Saldiva

2 joint publications

Bianca Ferreira

2 joint publications

Wânia Ferraz Pereira-Manfro

2 joint publications

Jorge Hallak